tirzepatide trials obesity trial non-diabetic pros and cons for weight loss A 72-week compared the two leading GLP-1 medications in adults with (no diabetes). The Tirzepatide outcompetes long-acting insulin in – oral tirzepatide clinical trial trials

The medication is often given as a once-weekly injection, making it convenient for ongoing treatment and chronic weight management

It's like, uh, you gotta eat more, you gotta eat more

Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea, Tel: +82-2-2072-1965, Fax: +82-2-2072-0318, E-mail: [email protected] Copyright 2021 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

however, human evidence for this effect remains limited and mixed, and it should be regarded as an area of ongoing research rather than established fact